These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 20799452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
    Wilkinson J.
    Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
    [No Abstract] [Full Text] [Related]

  • 3. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE, Calderon M, Milani M.
    Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
    [Abstract] [Full Text] [Related]

  • 4. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.
    Nelson H, Lehmann L, Blaiss MS.
    Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and tolerability of an SQ-standardized GRAss ALlergy immunotherapy tablet (GRAZAX®) in a real-life setting for three consecutive seasons - the GRAAL trial.
    Wessel F, Chartier A, Meunier JP, Magnan A.
    Clin Drug Investig; 2012 Jul 01; 32(7):451-63. PubMed ID: 22594491
    [Abstract] [Full Text] [Related]

  • 8. Sublingual immunotherapy.
    Frew AJ.
    N Engl J Med; 2008 May 22; 358(21):2259-64. PubMed ID: 18499568
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep 22; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 11. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
    Durham SR, Riis B.
    Allergy; 2007 Aug 22; 62(8):954-7. PubMed ID: 17620075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR, de Carpentier J.
    J Laryngol Otol; 2009 Jun 22; 123(6):683-4. PubMed ID: 18501039
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC, Hoyte EG, McIntire JJ, Umetsu DT.
    Ann Allergy Asthma Immunol; 2004 Jan 22; 92(1):25-31. PubMed ID: 14756461
    [Abstract] [Full Text] [Related]

  • 17. Is oral immunotherapy too good to be true?
    Ledford DK.
    Ann Allergy Asthma Immunol; 2004 Jan 22; 92(1):1-2. PubMed ID: 14756456
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
    Kleine-Tebbe J, Ribel M, Herold DA.
    Allergy; 2006 Feb 22; 61(2):181-4. PubMed ID: 16409193
    [Abstract] [Full Text] [Related]

  • 20. Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study.
    Pfaar O, Barth C, Jaschke C, Hörmann K, Klimek L.
    Int Arch Allergy Immunol; 2011 Feb 22; 154(4):336-44. PubMed ID: 20975285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.